Focus: Olympus is a public medical device and imaging company headquartered in Center Valley, PA, specializing in surgical products and diagnostic imaging across oncology, gastroenterology, respiratory, and women's health. With 201-500 employees, it operates as a mid-scale player in the medical technology space.
Profile data last refreshed 14h ago · AI intelligence enriched 3w ago
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Consider Olympus for mid-career stability in medical device innovation, but verify current hiring status and cash position before committing to applications.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Olympus
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Olympus's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Olympus buys BioProtect for $270m to tackle prostate cancer - BioXconomy
Olympus buys BioProtect for $270m to tackle prostate cancer BioXconomy
Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer - PR Newswire
Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer PR Newswire
Olympus Corp. Stock Hits Day Low Amid Price Pressure, Closing at JPY 1,688.00 - MarketsMojo
Olympus Corp. Stock Hits Day Low Amid Price Pressure, Closing at JPY 1,688.00 MarketsMojo
Olympus Corp stock (JP3197800000): Medical and industrial imaging focus draws investor interest - AD HOC NEWS
Olympus Corp stock (JP3197800000): Medical and industrial imaging focus draws investor interest AD HOC NEWS
Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript - Fortune
Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript Fortune
Adcock Ingram partners with Olympus to enhance endoscopy solutions in the region - IOL
Adcock Ingram partners with Olympus to enhance endoscopy solutions in the region IOL
Showing 6 of 10 news items
Based on last 2 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Normalization is essential for accurate intraoperative perfusion assessment using near-infrared fluorescence imaging.
Ameliorating Effect of Continuous Treatment With an Amorphous Formula of Curcumin on Maternal Imidacloprid Exposure-Induced Suppression of Hippocampal Neurogenesis in Rats.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo